Genfit S.A. (EPA:GNFT)
11.02
+0.30 (2.80%)
Jun 23, 2026, 5:38 PM CET
Genfit Revenue
In the year 2025, Genfit had annual revenue of 65.43M EUR, down -7.44%. Genfit had revenue of 29.90M in the half year ending December 31, 2025, with 54.34% growth.
Revenue
65.43M
Revenue Growth
-7.44%
P/S Ratio
8.39
Revenue / Employee
348.05K
Employees
188
Market Cap
548.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.43M | -5.26M | -7.44% |
| Dec 31, 2024 | 70.69M | 36.21M | 105.01% |
| Dec 31, 2023 | 34.48M | 8.24M | 31.38% |
| Dec 31, 2022 | 26.25M | -59.11M | -69.25% |
| Dec 31, 2021 | 85.36M | 76.67M | 883.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 156.33M |
| Cellectis | 65.14M |
| Nanobiotix | 32.59M |
| MedinCell | 32.44M |
| Innate Pharma | 9.01M |
| Transgene | 7.21M |
| Inventiva | 6.76M |
| Sensorion | 5.81M |
Genfit News
- 8 days ago - GENFIT: June 15, 2026 Combined Shareholders Meeting Results - GlobeNewsWire
- 15 days ago - GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp's OnDemand Offering for Identification of At-Risk MASH - GlobeNewsWire
- 4 weeks ago - Genfit Earnings release: Q1 2026 - Filings
- 2 months ago - Genfit Slides: Investor presentation - Filings
- 2 months ago - Genfit Annual report: Q4 2025 - Filings
- 2 months ago - Genfit Earnings release: Q4 2025 - Filings
- 4 months ago - Genfit Earnings release: Q4 2025 - Filings
- 7 months ago - Genfit Earnings release: Q3 2025 - Filings